Merck KGaA raises full-year forecast; Perlmutter’s new gig tackles ‘undruggable targets’
The Pharma Data
MAY 5, 2021
The editor of digital health’s newest journal wants to democratize medicine with data ( STAT ). FDA approves 100th monoclonal antibody product ( Nature Reviews Drug Discovery ). New variant-hardy AbCellera-Lilly mAb shows utility of viral genomics surveillance ( BioCentury ). Medtech.
Let's personalize your content